HOME >> MEDICINE >> NEWS
Timing of women's labor may determine effectiveness of pain medication

WINSTON-SALEM, N.C. Natural daily body rhythms may influence the effectiveness of spinal-epidural pain medication for women in labor, according to new research from Wake Forest University Baptist Medical Center. The study found that women who had day labor got longer pain relief than women with night labor with the same amount of labor pain medicine.

"Our research shows that the time of day that the medication is delivered is important in determining its effectiveness," said Peter H. Pan, M.D., an obstetrical anesthesiologist. "In the future, doctors may consider time of day, as well as patient's weight and other factors, when determining the best dose or method of drug delivery."

The study's goal was to determine if the body's natural internal rhythms can affect the effectiveness of pain medication for laboring women. The study, reported in the current issue of Anesthesiology, involved 77 women who were in labor with their first babies and requested spinal-epidural pain medication.

The research is part of the field of chronobiology that studies biologic rhythms. These rhythms include the circadian rhythm, the 24-hour body clock, and the ultradian rhythm, shorter-than-24-hour-cycles, which determine sleeping and eating patterns and can also affect blood pressure, heart rate and body temperature. Some rhythms are controlled by sunlight and others are controlled internally.

The researchers found that women who labored between noon and 6 p.m. got an average of 27 percent longer pain relief from a single dose of the spinal-epidural medication fentanyl than women whose labor was between 8 p.m. and 2 a.m. Fentanyl is one of the commonly used drugs for labor pain relief in the United States. However, this is one of the first studies to examine whether there are chronobiological variations in its effectiveness for labor pain relief.

"The right treatment given at the wrong time can be ineffective or create a crisis of escalating
'"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
15-Sep-2005


Page: 1 2

Related medicine news :

1. Timing of radiation treatments for colon cancer may need adjusting, Jefferson researchers say
2. Timing possible treatments against Alzheimers disease
3. Timing of introduction of gluten into infants diet associated with appearance of celiac disease
4. Moderate drinking lowers womens risk of heart attack
5. Prioritizing womens health
6. Updated guidelines advise focusing on womens lifetime heart risk
7. Extra cortisol protects womens mood under stress
8. Finger length ratio may predict womens sporting prowess
9. Weight worries affect womens motivation to stay smoke-free after pregnancy
10. Target womens depression to reduce disability from chronic conditions, suggests study
11. Race and income converge to shape womens experiences with advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... Plainview, NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and ... delivery arm of one of world’s largest healthcare services providers. , According ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... telemedicine platform, in which their iMedSecure™ comes included with each system installation. ... live images to remote participants for real-time collaboration and immediate decision-making requirements. ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced today the addition of ... in Biology from LSU, graduating summa cum laude. He attended Emory University School of ... in St. Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Business Architecture Body of Knowledge (BIZBOK® Guide )v 6.0 is now available for ... this effort through Guild collaborative teams. , Non-members may download the Part ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
(Date:7/10/2017)... PARK, N.C. , July 10, 2017 ... $5m Convertible Note to support the development of CRISPR-Cas3 ... Tencent Holdings Limited, a leading Chinese Internet services provider, ... funding will advance multiple infectious disease product programs targeting ... Founded by Dr. Rodolphe ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
Breaking Medicine Technology:
Cached News: